Back to Awarded Treatment Trials
Awarded Trial: 03T-350
Grant ID
03T-350
Illness
Schizophrenia
Primary Drug/Intervention
Riluzole
Primary Dosage
100mg
Secondary Drug Intervention
Risperidone
Secondary Dosage
4mg
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Terminated
Investigator
Rujescu
Sample Size
100
Duration of Study Period for Each Subject
4 weeks
Outcome Measurements
PANSS, BPRS, CGI, Extrapyramidal Sympton Rating Scale, Barnes Akathisia Scale
Results
The grant was terminated due to slow enrollment.
Publication
N/A
Link
N/A
PI Name
Dan Rujescu
Degree
MD
Center
Ludwig-Maximillians
Institution
Ludwig-Maximilians Universitaet, Dept. of Psychiatry
Address
Nussbaumstr. 7
City or Town
Munich
State or Province
N/A
Zip or Postal Code
80336
Country
Germany
Email Address
Dan.Rujescu@med.uni-muenchen.de